Appendix 2—table 29. Statin Non-user Cohort (Region=New York State) by BP Use, Patient Characteristics Pre/Post Match of BP Users/Non-users.
| Region=NY Statin Non-users by BP: Unmatched | Region=NY Statin Non-users by BP: Matched | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All | BP Non-users | BP Users | p-value | All | BP Non-users | BP Users | p-value | |||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |||
| All Patients | 185,536 | 100.0% | 170,990 | 92.2% | 14,546 | 7.8% | 29,042 | 100.0% | 14,521 | 50.0% | 14,521 | 50.0% | ||
| Age | ||||||||||||||
| ≤20 | 67 | 0.0% | 67 | 0.0% | 0 | 0.0% | <0.001 | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1.00 |
| 21-40 | 4,508 | 2.4% | 4,498 | 2.6% | 10 | 0.1% | 23 | 0.1% | 13 | 0.1% | 10 | 0.1% | ||
| 41-50 | 15,420 | 8.3% | 15,314 | 9.0% | 106 | 0.7% | 211 | 0.7% | 105 | 0.7% | 106 | 0.7% | ||
| 51-60 | 43,068 | 23.2% | 41,317 | 24.2% | 1,751 | 12.0% | 3,502 | 12.1% | 1,751 | 12.1% | 1,751 | 12.1% | ||
| 61-70 | 53,233 | 28.7% | 48,148 | 28.2% | 5,085 | 35.0% | 10,174 | 35.0% | 5,089 | 35.0% | 5,085 | 35.0% | ||
| 71-80 | 45,675 | 24.6% | 40,731 | 23.8% | 4,944 | 34.0% | 9,877 | 34.0% | 4,937 | 34.0% | 4,940 | 34.0% | ||
| ≥81 | 23,565 | 12.7% | 20,915 | 12.2% | 2,650 | 18.2% | 5,255 | 18.1% | 2,626 | 18.1% | 2,629 | 18.1% | ||
| Gender | ||||||||||||||
| Female | 107,420 | 57.9% | 94,242 | 55.1% | 13,178 | 90.6% | <0.001 | 26,304 | 90.6% | 13,151 | 90.6% | 13,153 | 90.6% | 0.97 |
| Male | 78,116 | 42.1% | 76,748 | 44.9% | 1,368 | 9.4% | 2,738 | 9.4% | 1,370 | 9.4% | 1,368 | 9.4% | ||
| Insurance | ||||||||||||||
| Commercial | 58,206 | 31.4% | 56,313 | 32.9% | 1,893 | 13.0% | <0.001 | 3,785 | 13.0% | 1,892 | 13.0% | 1,893 | 13.0% | 0.96 |
| Dual | 2,190 | 1.2% | 1,754 | 1.0% | 436 | 3.0% | 883 | 3.0% | 449 | 3.1% | 434 | 3.0% | ||
| Medicaid | 41,703 | 22.5% | 38,177 | 22.3% | 3,526 | 24.2% | 6,994 | 24.1% | 3,491 | 24.0% | 3,503 | 24.1% | ||
| Medicare | 83,437 | 45.0% | 74,746 | 43.7% | 8,691 | 59.7% | 17,380 | 59.8% | 8,689 | 59.8% | 8,691 | 59.9% | ||
| PCP Visit 2019 | ||||||||||||||
| No | 73,675 | 39.7% | 69,382 | 40.6% | 4,293 | 29.5% | <0.001 | 8,564 | 29.5% | 4,280 | 29.5% | 4,284 | 29.5% | 0.96 |
| Yes | 111,861 | 60.3% | 101,608 | 59.4% | 10,253 | 70.5% | 20,478 | 70.5% | 10,241 | 70.5% | 10,237 | 70.5% | ||
| Continuous Outcomes | ||||||||||||||
| mean | SD | mean | SD | mean | SD | p-value | mean | SD | mean | SD | mean | SD | p-value | |
| CCI | 1.08 | 1.76 | 1.09 | 1.76 | 0.95 | 1.75 | <0.001 | 0.95 | 1.74 | 0.95 | 1.73 | 0.95 | 1.75 | 0.82 |
BP: bisphosphonate; CCI: Charlson Comorbidity Index; PCP: primary care physician; SD: standard deviation.